Medically reviewed by Timothy W. Mackey, D.O. · Last reviewed: August 2026. Physician bio
Tirzepatide acts on two gut-hormone pathways, GLP-1 and GIP. It is commonly associated with Zepbound® and Mounjaro®. At NovaGenix it is a clinical decision after Timothy Mackey, D.O. reviews your history and medications—not an item you add to a cart.
Brand-name or compounded options are considered only when medically appropriate and legally available. Compounded availability can change with FDA shortage and compounding rules.
Semaglutide targets GLP-1 receptors. Tirzepatide targets GLP-1 and GIP. Both are typically weekly injections when used for weight management. Which option, if any, fits you depends on medical history, other drugs, tolerability, cost, and what is legally available—not on a website comparison chart.
Labeling for tirzepatide products used in weight management generally focuses on adults with obesity, or adults who are overweight with a related condition, when a clinician decides treatment is appropriate. That description is not a guarantee you will be prescribed it.
A personal or family history of medullary thyroid carcinoma or MEN2, prior serious hypersensitivity, pregnancy plans, and certain gastrointestinal or pancreatic histories can take this option off the table. Only an evaluation can say. See the FDA announcement on Zepbound (tirzepatide) and current prescribing information.
Labs are ordered when they are needed, not as a blanket rule. If they are required, we can help you obtain them. Follow-up watches side effects, whether the plan still makes sense, and whether a different medicine—or no medicine—is safer. Individual results vary.
Ask for current cash-pay ranges on the consult. Coverage is not assumed. Prices change with product type and follow-up frequency.